๐ฐ Eligo Bioscience News
Page 4 - Eligo Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eligo Bioscience. Real-time updates on events, politics, business and more.
April 4, 2022
Proposed approaches for eliminating or transferring gut microbes can be indiscriminate, so more selective approaches are in development.
February 2, 2022
JERSEY CITY, N.J., Feb. 2, 2022 /PRNewswire/ -- The newly published report titled "Global Animal Microbiome Market- By Trends, Industry Competition Analysis, Revenue (US$ Millions) and Forecast
February 2, 2022
/PRNewswire/ -- The newly published report titled "Global Animal Microbiome Marketโ By Trends, Industry Competition Analysis, Revenue (US$ Millions) and...
February 2, 2022
/PRNewswire/ -- The newly published report titled "Global Animal Microbiome Marketโ By Trends, Industry Competition Analysis, Revenue (US$ Millions) and...
December 3, 2021
Sanofi is to acquire Origimm Biotechnology in a move that gives the pharma giants a candidate to develop a first-in-class acne vaccine, which targets the skin microbiome and bacterial antigens that cause the skin condition.
December 3, 2021
Sanofi is to acquire Origimm Biotechnology in a move that gives the pharma giants a candidate to develop a first-in-class acne vaccine, which targets the skin microbiome and bacterial antigens that cause the skin condition.
December 3, 2021
Sanofi is to acquire Origimm Biotechnology in a move that gives the pharma giants a candidate to develop a first-in-class acne vaccine, which targets the skin microbiome and bacterial antigens that cause the skin condition.
December 2, 2021
/PRNewswire/ -- Eligo Bioscience today announced that the US Patent and Trademark Office (USPTO) has issued on Nov 19, 2021, a decision and a judgement...
December 2, 2021
/PRNewswire/ -- Eligo Bioscience today announced that the US Patent and Trademark Office (USPTO) has issued on Nov 19, 2021, a decision and a judgement...
October 29, 2021
GlaxoSmithKline (GSK) are to expand on an existing collaboration with Viome that looks into links between the gut microbiome and certain cancers.